(Q34343245)

1 August 2017

1 reference

title

Manipulating the immune system: humoral versus cell-mediated immunity (English)

1 reference

ORCID Public Data File 2021

1 August 2017

1 reference

author name string

McNeela EA

series ordinal

1

1 reference

1 August 2017

Mills KH

series ordinal

2

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Advanced Drug Delivery Reviews

1 August 2017

published in

1 reference

1 August 2017

volume

51

1 reference

1 August 2017

issue

1-3

1 reference

1 August 2017

page(s)

43-54

1 reference

Vaccines for mucosal immunity to combat emerging infectious diseases

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Recognition of foreign antigen by T cells and their role in immune protection

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

The expanding universe of T-cell subsets: Th1, Th2 and more.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Innate immunity: the virtues of a nonclonal system of recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: effect of formulation and route of immunization on induction of Th1 and Th2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Induction of cytotoxic T-cell responses following oral immunization with synthetic peptides encapsulated in PLG microparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Intranasal immunization with polymer-grafted microparticles activates the nasal-associated lymphoid tissue and draining lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Generation of protective immune responses to plague by mucosal administration of microsphere coencapsulated recombinant subunits

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Immunological activity of chitin and its derivatives.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Stimulation of cytokine production in mice using deacetylated chitin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

The adjuvant combination monophosphoryl lipid A and QS21 switches T cell responses induced with a soluble recombinant HIV protein from Th2 to Th1

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

A comparison of immunogenicity and in vivo distribution of Salmonella enterica serovar Typhi and Typhimurium live vector vaccines delivered by mucosal routes in the murine model.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Engineering the microflora to vaccinate the mucosa: serum immunoglobulin G responses and activated draining cervical lymph nodes following mucosal application of tetanus toxin fragment C-expressing lactobacilli

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Chimeric plant virus particles administered nasally or orally induce systemic and mucosal immune responses in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Liposomes as an immunoadjuvant system for stimulation of mucosal and systemic antibody responses against inactivated measles virus administered intranasally to mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Activation of systemic and mucosal immune response following nasal administration of liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

A controlled clinical study of the effect of nasal immunization with a Streptococcus mutans antigen alone or incorporated into liposomes on induction of immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Intranasal immunization with liposome-formulated Yersinia pestis vaccine enhances mucosal immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Interferon-gamma inductive effect of liposomes as an immunoadjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Nasal immunization of mice with Cryptosporidium parvum DNA induces systemic and intestinal immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Protective DNA immunization against Chlamydia pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Enhancement of mucosal immune responses to the influenza virus HA protein by alternative approaches to DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Mucosal immunization with DNA-liposome complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Naked DNA when co-administered intranasally with heat-labile enterotoxin of Escherichia coli primes effectively for systemic B- and T-cell responses to the encoded antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Interleukin 12 and innate molecules for enhanced mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Intranasal administration of human immunodeficiency virus type-1 (HIV-1) DNA vaccine with interleukin-2 expression plasmid enhances cell-mediated immunity against HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Ceramide signalling and the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin: distinct pro- and anti-inflammatory effects of the nontoxic AB complex and the enzyme activity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor beta1 and beta2 chain expression

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Genetically detoxified mutants of heat-labile enterotoxin from Escherichia coli are effective adjuvants for induction of cytotoxic T-cell responses against HIV-1 gag-p55.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Effectiveness of intranasal immunization with HIV-gp160 and an HIV-1 env CTL epitope peptide (E7) in combination with the mucosal adjuvant LT(R192G)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Safety and immunogenicity of intranasally administered inactivated trivalent virosome-formulated influenza vaccine containing Escherichia coli heat-labile toxin as a mucosal adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Intranasal booster vaccination against diphtheria and tetanus in man

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Safety and immunogenicity testing of an intranasal group B meningococcal native outer membrane vesicle vaccine in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Induction of antigen-specific T cell responses in human volunteers after intranasal immunization with a whole-cell pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

Whole-cell but not acellular pertussis vaccines induce convulsive activity in mice: evidence of a role for toxin-induced interleukin-1beta in a new murine model for analysis of neuronal side effects of vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900169-7

7 January 2021

10.1016/S0169-409X(01)00169-7

Identifiers

DOI

1 reference

1 August 2017

1 reference